At MFMac, we bring deep sectoral insight to support the innovation, growth and resilience of Scotland’s healthcare and life sciences ecosystem. Recognised as a Tier 1 team by Legal 500 and ranked Band 2 by Chambers and Partners, our cross-disciplinary legal team advises clients across the public and private sectors – from NHS Boards and biotech start-ups to care providers, med-tech innovators and private healthcare organisations.









At MFMac, we provide strategic legal guidance to healthcare and life sciences organisations operating in a complex and fast-evolving regulatory landscape. Our cross-disciplinary team supports clients from early-stage research through to commercialisation, helping them manage risk, ensure compliance and scale with confidence.
Our healthcare lawyers advise on regulatory matters, quality assurance and data governance and we structure R&D agreements including sponsorships, collaborations, MTAs and CDAs. Our expertise also covers clinical trial agreements, commercial contracts – such as licensing, distribution, consultancy, supply and manufacturing – and CRO arrangements. In addition, we help clients protect and maximise their intellectual property.


At MFMac, we help healthcare and life sciences businesses scale with confidence.
Our commercially focused legal support will help power your growth through all the phases and stages – whether that is around strategic structuring, supply chain management, attracting investment or planning expansion. From mergers and acquisitions to joint ventures and capital fundraising, we deliver pragmatic legal solutions that drive innovation, unlock investment and support ambition.

MFMac advises clients across the healthcare and life sciences sector (including care providers, bioTech, medtech, digital health and patient technologies and data and AI-driven life sciences) on commercial, regulatory and transactional matters. Our sector-focused team delivers practical legal solutions that support innovation and growth.

The Home Office has announced its approach to earned settlement, also known as indefinite leave to remain (ILR). The reforms offer protection for some existing care workers, but others may face longer routes to settlement and additional visa costs. Implementation is planned during 2027, but detailed Immigration Rules and guidance are still awaited, as well as the official timeline.

MFMac advised Pilrig Dental Practice Ltd on the acquisition of Pilrig Dental Practice, providing legal support across corporate, real estate, employment and pensions matters. The transaction completed successfully on 28 August 2026, enabling the client to acquire a well-established dental practice and support its continued growth.

This article highlights the key legal and commercial issues life sciences organisations should address when entering collaboration agreements, including IP, data sharing, regulatory compliance, funding, liability and termination. Getting these fundamentals right helps partners work together effectively and maximise the chances of successful innovation and commercialisation.

Using wearable health technology as a practical case study, MFMac's Glasgow Tech Week event on Innovation, Regulation and Real Time Health Monitoring will examine how data protection, cyber security and product liability risks shape innovation across the product lifecycle.
MFMac advises healthcare and life sciences clients on IP, IT, immigration and regulatory compliance – supporting innovation, protecting assets and navigating complex legal frameworks.
Our dedicated team of legal experts brings deep sector insight and proven experience to support healthcare and life sciences leaders in navigating complex regulations, protecting innovation and accelerating growth.